bluebird bio, Inc. (BLUE) Financials

NASDAQ Currency in USD Disclaimer

$7.79

north_east $0.13 (1.7%)
Day's range
$7.57
Day's range
$8.24

BLUE Income statement / Annual

Last year (2023), bluebird bio, Inc.'s total revenue was $29.50 M, an increase of 720.04% from the previous year. In 2023, bluebird bio, Inc.'s net income was -$211.91 M. See bluebird bio, Inc.�s key income statements, including revenue, expenses, profit, and income.

Period FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015 FY-2014
Period Ended 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Operating Revenue $29.50 M $3.60 M $3.66 M $250.73 M $44.67 M $54.58 M $35.43 M $6.16 M $14.08 M $25.42 M
Cost of Revenue $33.53 M $10.08 M $38.86 M $5.40 M $2.98 M $885,000.00 $1.53 M $204.78 M $123.74 M $62.57 M
Gross Profit -$4.03 M -$6.48 M -$35.20 M $245.34 M $41.70 M $53.69 M $33.90 M -$198.62 M -$109.66 M -$37.15 M
Gross Profit Ratio -0.14 -1.8 -9.61 0.98 0.93 0.98 0.96 -32.27 -7.79 -1.46
Research and Development Expenses $167.65 M $240.76 M $319.95 M $587.96 M $582.41 M $448.59 M $273.04 M $204.78 M $134.04 M $62.57 M
General & Administrative Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $174.13 M $93.55 M $65.12 M $46.21 M $23.23 M
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $165.51 M $136.91 M $209.97 M $286.90 M $271.36 M $174.13 M $93.55 M $65.12 M $46.21 M $23.23 M
Other Expenses -$92.93 M -$102.00 M $27.65 M -$6.50 M -$10.09 M $1.96 M -$1.27 M $3.71 M $2.31 M $120,000.00
Operating Expenses $240.23 M $275.67 M $529.92 M $874.85 M $853.78 M $622.72 M $366.59 M $269.89 M $180.25 M $85.80 M
Cost And Expenses $273.76 M $285.75 M $568.77 M $880.25 M $856.75 M $623.60 M $368.12 M $269.89 M $180.25 M $85.80 M
Interest Income $9.87 M $1.03 M $879,000.00 $11.54 M $34.76 M $0.00 $0.00 $0.00 $1.59 M $152,000.00
Interest Expense $16.35 M $6.32 M $0.00 $0.00 $34.76 M $14.62 M $0.00 $0.00 $1.59 M $152,000.00
Depreciation & Amortization $28.53 M $5.00 M $5.45 M $5.63 M $17.43 M $17.16 M $13.54 M $9.65 M $7.42 M $4.23 M
EBITDA -$167.16 M -$215.56 M -$556.93 M -$553.63 M -$772.72 M -$551.87 M -$319.15 M -$254.47 M -$159.30 M -$56.15 M
EBITDA Ratio -5.67 -77.07 -147.27 -2.54 -18.12 -10.37 -9.41 -42.18 -11.6 -2.37
Operating Income Ratio -8.28 -79.81 -161.36 -2.51 -18.18 -10.48 -9.38 -43.51 -12.01 -2.38
Total Other Income/Expenses Net $32.22 M $19.96 M $28.53 M -$1.11 M $24.67 M $16.59 M -$3.27 M $3.71 M $2.31 M $120,000.00
Income Before Tax -$212.04 M -$266.46 M -$562.38 M -$618.01 M -$790.15 M -$555.44 M -$335.43 M -$264.12 M -$166.72 M -$60.51 M
Income Before Tax Ratio -7.19 -74.08 -153.57 -2.46 -17.69 -10.18 -9.47 -42.91 -11.84 -2.38
Income Tax Expense -$126,000.00 $117,000.00 $258,000.00 $686,000.00 -$545,000.00 $187,000.00 $210,000.00 -$612,000.00 $60,000.00 -$11.80 M
Net Income -$211.91 M -$266.58 M -$562.64 M -$618.70 M -$789.61 M -$555.63 M -$335.64 M -$263.51 M -$166.78 M -$48.71 M
Net Income Ratio -7.18 -74.11 -153.64 -2.47 -17.67 -10.18 -9.47 -42.81 -11.85 -1.92
EPS -1.93 -3.39 -8.16 -9.95 -14.31 -10.68 -7.71 -7.07 -4.81 -1.83
EPS Diluted -1.93 -3.39 -8.16 -9.95 -14.31 -10.68 -7.71 -7.07 -4.81 -1.83
Weighted Average Shares Out $109.83 M $78.59 M $68.91 M $62.18 M $55.19 M $52.03 M $43.54 M $37.28 M $34.67 M $26.55 M
Weighted Average Shares Out Diluted $109.83 M $78.59 M $68.91 M $62.18 M $55.19 M $52.03 M $43.54 M $37.28 M $34.67 M $26.55 M
Link